局部Janus激酶抑制剂:皮肤病学应用综述
本文综述了截至2017年11月PubMed和Cochrane图书馆中关于局部JAK抑制剂治疗炎症性皮肤病的证据,共纳入11篇文章、924例患者。随机临床试验显示局部JAK抑制剂对银屑病和特应性皮炎疾病评分、患者报告结局及生活质量有适度改善,对白癜风结果矛盾,仅面部白癜风有改善,斑秃缺乏确切疗效数据。
要点
- 局部JAK抑制剂在随机临床试验中对银屑病和特应性皮炎有适度改善。
- 白癜风结果矛盾,仅面部白癜风观察到改善。
- 斑秃缺乏确切疗效数据,需大规模3期和4期研究进一步明确。
核心结论
- 局部JAK抑制剂为银屑病、特应性皮炎、斑秃和白癜风患者提供了一种有吸引力的治疗选择。
- 尽管早期临床研究有前景,仍需大规模3期和4期研究进一步明确局部JAK抑制剂在皮肤病学中的作用。
研究设计与样本
- 本文为综述,检索PubMed和Cochrane图书馆截至2017年11月的文章。
- 共识别55篇潜在文章,纳入11篇进行综述,合计924例患者。
主要发现
- 在随机临床试验中,局部JAK抑制剂对银屑病和特应性皮炎疾病评分、患者报告结局及生活质量显示适度改善。
- 白癜风结果矛盾,仅面部白癜风观察到改善。
- 斑秃缺乏确切疗效数据。
局限性
- 由于缺乏标准化和随机临床试验数量少,无法进行Meta分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Janus kinase (JAK) inhibitors have attracted attention for their role in treating inflammatory disorders. This new class of biologics has the potential to significantly affect the field of dermatology, especially with the development of topical formulations. OBJECTIVE: To summarize published evidence on the efficacy, safety, and tolerability of topical JAK inhibitors in the treatment of inflammatory skin conditions. METHODS: This is a review of articles available in PubMed and the Cochrane Library up until November 2017. RESULTS: Fifty-five potential articles were identified; 11 articles were included for review, comprising an aggregate of 924 patients. In randomized clinical trials, topical JAK inhibitors demonstrate modest improvements in psoriasis and atopic dermatitis disease scores, patient-reported outcomes, and quality of life. Results for vitiligo are conflicting, with improvements seen only in facial vitiligo. Conclusive efficacy data for alopecia areata is lacking. LIMITATIONS: It was not possible to perform a meta-analysis due to the lack of standardization and low number of randomized clinical trials. CONCLUSION: Topical JAK inhibitors provide an attractive treatment option for patients with psoriasis, atopic dermatitis, alopecia areata, and vitiligo. Although early phase clinical studies of this novel drug class are promising, large phase 3 and 4 studies are needed to further define the role of topical JAK inhibitors in dermatology.
引用
- Hosking AM, Juhasz M, Mesinkovska NA, et al. Topical Janus kinase inhibitors: A review of applications in dermatology. J Am Acad Dermatol. 2018. PMID: 29673776. doi:10.1016/j.jaad.2018.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。